Moore Capital Management »

Pmv Pharmaceuticals shares owned by Moore Capital Management

Quarter-by-quarter ownership of Pmv Pharmaceuticals (PMVP) shares owned by Moore Capital Management from 13F filings

Historical chart of Moore Capital Management investment in Pmv Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pmv Pharmaceuticals held by Moore Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pmv Pharmaceuticals by Moore Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $322k 104k 3.10
2023-09-30 $1.9M 305k 6.14

More positions owned by Moore Capital Management

Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Meta Platforms Cl A (META)
Amazon (AMZN)
Ishares Tr Msci Emg Mkt Etf (EEM)
Spdr Ser Tr S&p Biotech (XBI)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Palo Alto Networks Note 0.375% 6/0 (Principal)
Ally Financial (ALLY)
Allstate Corporation (ALL)
Spdr Ser Tr S&p Regl Bkg (KRE)
Vaneck Etf Trust Gold Miners Etf (GDX)
salesforce (CRM)
Progressive Corporation (PGR)
Vertiv Holdings Com Cl A (VRT)
Select Sector Spdr Tr Indl Call Option (XLI)

View all positions for Moore Capital Management

Top funds holding Pmv Pharmaceuticals

OrbiMed Advisors
Jpmorgan Chase & Co
Arrowpoint Asset Management
Euclidean Capital
Vanguard Group
Partner Fund Management
Bank of America Corporation
BML Capital Management
Citadel Advisors
Goldman Sachs Group
Point72 Asset Management
Federated Investors
Vontobel Holding
EcoR1 Capital
Dimensional Fund Advisors

View all funds holding Pmv Pharmaceuticals